ACS Chemical Neuroscience

Scope & Guideline

Pioneering Research at the Nexus of Chemistry and Cognition.

Introduction

Immerse yourself in the scholarly insights of ACS Chemical Neuroscience with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1948-7193
PublisherAMER CHEMICAL SOC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2010 to 2024
AbbreviationACS CHEM NEUROSCI / ACS Chem. Neurosci.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1155 16TH ST, NW, WASHINGTON, DC 20036

Aims and Scopes

ACS Chemical Neuroscience is dedicated to advancing the understanding of chemical processes in the nervous system, focusing on the intersection of chemistry and neuroscience. The journal publishes original research that explores the molecular mechanisms underlying neurological diseases, the development of novel therapeutic agents, and innovative methodologies for studying the brain.
  1. Neurochemical Modulation and Drug Development:
    A primary focus of the journal is the exploration of neurochemical pathways and the design of pharmacological agents aimed at modulating these pathways to treat neurological disorders such as Alzheimer's, Parkinson's, and depression.
  2. Molecular Mechanisms of Neurodegeneration:
    Research articles often delve into the molecular underpinnings of neurodegenerative diseases, investigating protein aggregation, oxidative stress, and neuroinflammation as key factors in disease progression.
  3. Innovative Therapeutic Strategies:
    The journal emphasizes the development of innovative strategies for neuroprotection and neuroregeneration, including the use of small molecules, peptides, and biologics to target specific pathways involved in neuronal health.
  4. Advanced Imaging Techniques:
    Articles frequently highlight advancements in imaging modalities, such as PET and MRI, which are crucial for understanding brain function and pathology at a molecular level.
  5. Translational Research:
    The journal promotes research that bridges the gap between laboratory discoveries and clinical applications, focusing on the therapeutic potential of new compounds and their mechanisms of action.
The field of chemical neuroscience is dynamic, with emerging themes reflecting the latest scientific advancements and societal needs. Recent publications indicate several trending and emerging scopes that are gaining attention.
  1. Neuroinflammation and Immune Modulation:
    There is a marked increase in research investigating the role of neuroinflammation in various neurological disorders, along with approaches to modulate the immune response as a therapeutic strategy.
  2. Psychedelic Compounds and Their Therapeutic Potential:
    Recent papers have highlighted the exploration of psychedelics, such as psilocybin and LSD, for their potential therapeutic effects in treating mood disorders and other neuropsychiatric conditions, indicating a resurgence of interest in this area.
  3. Artificial Intelligence and Machine Learning Applications:
    The integration of AI and machine learning in drug discovery and neuroimaging is on the rise, reflecting a trend towards computational approaches that enhance the understanding of complex neurobiological systems.
  4. Targeted Protein Degradation Technologies:
    Research on targeted protein degradation, particularly in the context of neurodegenerative diseases, is gaining momentum as a novel therapeutic strategy to eliminate toxic protein aggregates.
  5. Gut-Brain Axis Research:
    There is an increasing focus on the gut-brain axis and its implications for neurodegenerative diseases and mental health, reflecting a broader understanding of the interconnectedness of physiological systems.

Declining or Waning

While ACS Chemical Neuroscience continues to thrive in several research areas, certain themes appear to be declining in prominence based on recent publication trends. This section highlights those waning scopes.
  1. Classical Neuropharmacology:
    Research focusing solely on classical neuropharmacological agents, such as traditional antidepressants or anxiolytics, seems to be losing traction as the field shifts towards more complex, multimodal approaches to treatment.
  2. Basic Neuroanatomy Studies:
    Basic studies in neuroanatomy without a clear connection to functional implications or therapeutic applications are becoming less frequent, reflecting a shift towards more integrated and applied research.
  3. Single Target Drug Development:
    The trend towards developing single-target drugs appears to be waning, as there is a growing emphasis on multitarget approaches that address the multifaceted nature of neurological disorders.
  4. In Vitro Models with Limited Relevance:
    Research relying heavily on traditional in vitro models lacking translational relevance to human physiology is decreasing, as there is a greater demand for studies utilizing more sophisticated in vivo or organoid models.

Similar Journals

Translational Neuroscience

Exploring Innovative Frontiers in Neurological Research.
Publisher: DE GRUYTER POLAND SP Z O OISSN: 2081-3856Frequency: 1 issue/year

Translational Neuroscience, published by DE GRUYTER POLAND SP Z O O, is a leading open-access journal since its inception in 2015, dedicated to the multidisciplinary exploration of neurological research and its clinical applications. With an ISSN of 2081-3856 and an E-ISSN of 2081-6936, the journal serves as a crucial platform for scholars and practitioners to disseminate innovative findings and theoretical advancements in the field of neuroscience. Covering various aspects of general neuroscience, it is ranked in the Q3 quartile for 2023 and positioned at Rank #75 out of 113 in its category, reflecting its growing impact within the scientific community. The journal strives to bridge the gap between laboratory research and clinical practice, fostering collaboration among researchers, clinicians, and educators. The editorial team is committed to maintaining high publication standards that engage the audience with rigorous research while promoting a culture of open science. For those interested in the forefront of neuroscience research, Translational Neuroscience offers an invaluable resource for knowledge and innovation.

Journal of Neuroimmune Pharmacology

Transforming Understanding of Neuroimmune Interactions
Publisher: SPRINGERISSN: 1557-1890Frequency: 4 issues/year

The Journal of Neuroimmune Pharmacology, published by Springer, is a premier academic journal dedicated to advancing the field of pharmacology intersecting with neuroscience and immunology. With an outstanding impact factor and proudly positioned in the Q1 quartile across multiple categories, this journal showcases cutting-edge research that enhances our understanding of the neuroimmune system and its pharmacological implications. Established in 2006 and continuing through 2024, it serves as a vital resource for researchers, professionals, and students alike, offering insights into the mechanisms of drug action, disease processes, and therapeutic strategies. As a testament to its excellence, the journal ranks prominently in Scopus metrics within its discipline, making it an essential platform for disseminating high-quality research that drives innovation in immunology, allergy, neuroscience, and pharmacology.

JOURNAL OF MOLECULAR NEUROSCIENCE

Empowering Researchers to Decode Neural Mechanisms
Publisher: SPRINGERNATUREISSN: 0895-8696Frequency: 9 issues/year

Journal of Molecular Neuroscience, published by SpringerNature, is a critical resource for researchers and professionals in the dynamic field of neuroscience. With ISSN 0895-8696 and E-ISSN 1559-1166, this journal has established itself as a key player since its inception in 1989, covering a range of topics within Cellular and Molecular Neuroscience and Medicine (miscellaneous). Its impressive rankings, including being placed in the Q2 quartile for Medicine and Q3 for Cellular and Molecular Neuroscience, underscore its scholarly impact, featuring innovative research that informs and advances our understanding of neural processes. The journal does not currently operate under an open-access model, providing rich, peer-reviewed content geared towards academics and professionals seeking comprehensive analyses and breakthroughs in molecular neurobiology. With a publication window extending to 2024, the Journal of Molecular Neuroscience remains dedicated to enhancing the scientific community's knowledge landscape, making it an essential reference for those passionate about unraveling the complexities of the nervous system.

JOURNAL OF CHEMICAL NEUROANATOMY

Advancing Insights into Neuroanatomical Complexity
Publisher: ELSEVIERISSN: 0891-0618Frequency: 8 issues/year

JOURNAL OF CHEMICAL NEUROANATOMY, published by Elsevier, focuses on the intersection of neuroscience and chemical processes, making it an essential resource for researchers and professionals in the field. With a commitment to advancing the understanding of the cellular and molecular underpinnings of neuroanatomy, this journal has provided a platform for innovative research since its inception in 1988, with its current dissemination period extending through 2024. Operating from the Netherlands, it has earned its place in the Q3 category of cellular and molecular neuroscience as per the 2023 assessments. While it currently does not offer Open Access options, the journal remains a valuable asset in disseminating cutting-edge studies that explore the complexity of the nervous system. With its ISSN 0891-0618 and E-ISSN 1873-6300, the journal serves a diverse audience, including researchers, clinicians, and students, fostering collaboration and innovation in the ever-evolving field of neuroanatomy.

Science Bulletin

Connecting ideas, shaping the future of science.
Publisher: ELSEVIERISSN: 2095-9273Frequency: 24 issues/year

Science Bulletin is a premier multidisciplinary journal published by Elsevier, renowned for its commitment to advancing scientific knowledge across various fields. With an impressive impact factor and achieving a distinguished Q1 category ranking in 2023 within its multidisciplinary scope, Science Bulletin stands out for its rigorous peer-review process and high-quality research dissemination. Since its inception in 2015, the journal has been pivotal in bridging gaps between diverse scientific disciplines, fostering collaboration and innovation. Researchers and professionals can benefit from its Open Access options, ensuring wider visibility and accessibility of groundbreaking research. With a Scopus rank of #4 out of 171, placing it in the 97th percentile, Science Bulletin continues to set the standard for scholarly excellence, making it an essential resource for those seeking to stay at the forefront of scientific discovery.

TRENDS IN NEUROSCIENCES

Navigating the Evolving Landscape of Neuroscience
Publisher: CELL PRESSISSN: 0166-2236Frequency: 12 issues/year

TRENDS IN NEUROSCIENCES, published by CELL PRESS, is a leading journal in the field of neuroscience, offering cutting-edge insights and important developments in the rapidly evolving landscape of brain research. With an impressive Impact Factor and ranking in the top quartile (Q1) of the category for Neuroscience (miscellaneous), it is positioned as a vital resource for researchers and professionals seeking to stay abreast of the latest discoveries and trends from 1978 to the present. Specifically ranked #3 out of 113 in General Neuroscience by Scopus, this journal promotes the interdisciplinary exchange of ideas and knowledge, making it an essential platform for students and experienced scholars alike. Although it is not an Open Access journal, its value lies in its rigorous peer-review process and commitment to maintaining the highest standards of academic integrity. By continuing to explore the complexities of neural processes and behavior, TRENDS IN NEUROSCIENCES plays a crucial role in shaping the future of neuroscience research and education.

NeuroSci

Advancing Neuroscience Through Open Collaboration
Publisher: MDPIISSN: Frequency: 4 issues/year

NeuroSci is an esteemed open-access journal published by MDPI, dedicated to advancing the field of neuroscience through high-quality research dissemination. Operating under the E-ISSN 2673-4087, this journal aims to foster collaboration and innovation by providing a platform for original research articles, reviews, and theoretical studies that address the complexities of the brain and nervous system. NeuroSci encourages submissions from a wide array of disciplines including cognitive neuroscience, neurobiology, neurophysiology, and neuropsychology, making it an essential resource for researchers, professionals, and students alike. With its commitment to open accessibility, NeuroSci ensures that groundbreaking findings are readily available to the global community, thereby enhancing the impact and exchange of knowledge in neuroscience. The journal is located at ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND, contributing to the reputation of MDPI as a leading publisher in the academic landscape.

NEUROSCIENCE RESEARCH

Advancing the Frontiers of Neural Discovery
Publisher: ELSEVIER IRELAND LTDISSN: 0168-0102Frequency: 12 issues/year

NEUROSCIENCE RESEARCH, published by Elsevier Ireland Ltd, is a leading journal in the field of neuroscience, with a notable reputation for disseminating high-quality research that spans a variety of topics within the discipline. With an ISSN of 0168-0102 and an E-ISSN of 1872-8111, this journal serves as a vital platform for both established researchers and emerging voices in the field. Ranking in the Q2 quartile in both Medicine and Neuroscience categories, it has been recognized as a reliable source of innovative findings since its inception in 1984, with continuous publication through 2024. Although it does not currently offer Open Access options, the journal is indexed in Scopus, holding a significant position at Rank #48/113 in General Neuroscience, reflecting its contribution to advancing the understanding of neural mechanisms across various contexts. With its address anchored in Ireland, NEUROSCIENCE RESEARCH plays an essential role in bridging scientific inquiry and practical applications, making it an indispensable resource for researchers, professionals, and students dedicated to the burgeoning field of neuroscience.

Neural Regeneration Research

Pioneering breakthroughs in the science of recovery.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1673-5374Frequency: 12 issues/year

Neural Regeneration Research is a premier Open Access journal, published by Wolters Kluwer Medknow Publications, dedicated to advancing the field of Developmental Neuroscience. Since its inception, the journal has established itself as a valuable resource for researchers, professionals, and students alike, providing a comprehensive platform for disseminating the latest findings and methodologies in neural regeneration. With an impressive Scopus Ranks placement of #3 out of 49 in its category and a Q2 Quartile ranking, the journal boasts a significant impact within the academic community, reflecting its high quality and relevance. Since adopting an Open Access model in 2011, it has expanded access to critical research in neural regeneration, fostering collaboration and innovation among scholars globally. Covering various aspects of neuroscience, its converged years from 2006 to 2025 highlight the journal's commitment to ongoing discourse and discovery. Situated in China, the journal not only promotes local insights but also connects the global research community to pressing topics in neuroscience, making it an essential read for anyone involved in this dynamic field.

NEUROREPORT

Pioneering insights into cognitive and neuropharmacological studies.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0959-4965Frequency: 18 issues/year

NEUROREPORT is a distinguished journal in the field of neuroscience, published by Lippincott Williams & Wilkins. With an ISSN of 0959-4965 and an E-ISSN of 1473-558X, the journal has established itself as a vital platform for disseminating innovative research and developments in the dynamic area of neuroscience since its inception in 1990. Currently, it is positioned in the Q3 category of the 2023 Journal Rankings, reflecting its respectable standing within the community of neuroscience professionals, ranked #74 out of 113 in general neuroscience on Scopus, placing it in the 34th percentile. While it operates on a traditional subscription model, NEUROREPORT is committed to fostering knowledge sharing in the realm of neurobiology, neuropharmacology, and cognitive studies among researchers, professionals, and students alike. With its broad scope and commitment to scientific excellence, the journal continues to be a cornerstone for those seeking to stay ahead in the evolving landscape of neurological research.